Mettler-Toledo International Inc.


SKU: MTD Category:


Mettler-Toledo International delivered a mixed set of results in its most recent result, with revenues falling short of Wall Street expectations but above-par earnings. In the third quarter, they reported sales of $942.5 million, indicating a 5% decline in local currency, while US dollar-based sales dropped by 4%, with currency effects contributing a 1% increase. Laboratory sales contracted by 9%, industrial by 6%, and food retail surged by 49%. On the other hand, service sales experienced a 6% increase in the quarter. Notably, a decline in demand was observed, particularly in China, where pharma and biopharma customers reduced investments after significant spending during the pandemic. Looking ahead to 2024, the management remains optimistic about the lab business’s fundamentals, expecting a normalization in pharma and biopharma activity and anticipating long-term strength in innovation pipelines. In the Industrial business, sales declined 6% in the quarter due to weak core industrial product sales, particularly in China and the Americas. Food Retail witnessed strong growth in the Americas, with successful penetration into major grocery and club stores. However, the management anticipates modest revenue declines in 2024 due to challenging growth comparisons.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!